|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 2004; 43:1145-1148, doi:10.1016/j.jacc.2003.10.050 © 2004 by the American College of Cardiology Foundation |
* Department of Cardiovascular Medicine, Ochsner Clinic Foundation, New Orleans, Louisiana, USA
University of California School of Medicine, San Diego, California, USA
Manuscript received March 10, 2003; revised manuscript received June 24, 2003, accepted October 21, 2003.
* Reprint requests and correspondence: Dr. Mandeep R. Mehra, Ochsner Clinic Foundation, Cardiology Department, 1514 Jefferson Highway, New Orleans, Louisiana 70121, USA.
mmehra{at}ochsner.org
The device era in heart failure has been heralded by successes in the realm of pacemakers, implantable defibrillators, and ventricular assist devices. In particular, the concept of cardiac resynchronization therapy, which seeks to optimize ventricular contractility by decreasing areas of focal dyssynchrony, is gaining wide acceptance. Recent trials of cardiac resynchronization therapy have suggested that this treatment modality yields benefits that are reflected in improved functional capacity, reversal of ventricular modeling, and decreased hospitalizations. Cardiac resynchronization device therapy exerts a substantial placebo effect, with evidence of improved functional capacity and quality-of-life parameters in almost half of those in the control group, probably as a result of device implantation. Furthermore, analysis of the different trials suggests heterogeneity of response (differences in magnitude of observed benefit between trials presumably enrolling similar heart-failure populations) and a large non-responder rate (no improvement in functional capacity and well-being). The appropriate approach to resynchronization must include much more than simple characteristics of device implantation. We must detect the presence and precise location of mechanical dyssynchrony and be able to find the technical location and place the pacing leads in the appropriate position. Finally, we must be able to show evidence for sustained improvement in ventricular dyssynchrony. Thus, the current approach to resynchronization represents a "best guess" approach to achieving resynchronization by observation of surrogate responses. Continued investigation to determine optimal approaches for achieving a beneficial clinical response is essential to ensure that cardiac resynchronization therapy is offered to those most likely to benefit.
| ||||||||||||
This article has been cited by other articles:
|
|
 |
|
  R Chung, R Sutton, and M Y Henein Beyond dyssynchrony in cardiac resynchronisation therapy Heart, August 1, 2008; 94(8): 991 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N R Van de Veire, J De Sutter, J J Bax, and J R T C Roelandt Technological advances in tissue Doppler imaging echocardiography Heart, August 1, 2008; 94(8): 1065 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N R Van de Veire, C-M Yu, N Ajmone-Marsan, G B Bleeker, C Ypenburg, J De Sutter, Q Zhang, J W H Fung, J Y S Chan, E R Holman, et al. Triplane tissue Doppler imaging: a novel three-dimensional imaging modality that predicts reverse left ventricular remodelling after cardiac resynchronisation therapy Heart, March 1, 2008; 94(3): e9 - e9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. McAlister, J. Ezekowitz, N. Hooton, B. Vandermeer, C. Spooner, D. M. Dryden, R. L. Page, M. A. Hlatky, and B. H. Rowe Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction: A Systematic Review JAMA, June 13, 2007; 297(22): 2502 - 2514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Greenberg and M. R. Mehra All Patients With Heart Failure and Intraventricular Conduction Defect or Dyssynchrony Should Not Receive Cardiac Resynchronization Therapy Circulation, December 12, 2006; 114(24): 2685 - 2691. [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Van de Veire, J. D. Schuijf, J. De Sutter, D. Devos, G. B. Bleeker, A. de Roos, E. E. van der Wall, M. J. Schalij, and J. J. Bax Non-Invasive Visualization of the Cardiac Venous System in Coronary Artery Disease Patients Using 64-Slice Computed Tomography J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1832 - 1838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T R Betts Rhythm control strategies for "symptomatic" persistent atrial fibrillation: is achieving sinus rhythm enough? Heart, September 1, 2006; 92(9): 1189 - 1190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Hauptman Palliation in heart failure: When less and more are more American Journal of Hospice and Palliative Medicine, March 1, 2006; 23(2): 150 - 152. [PDF]
|
|
|
|
 |
|
 F. A. McAlister, J. V. Tu, A. Newman, D. S. Lee, S. Kimber, B. Cujec, and P. W. Armstrong How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts Eur. Heart J., February 1, 2006; 27(3): 323 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bisleri, T. Bottio, and C. Muneretto Minimally Invasive Surgical Placement of Left Ventricular Epicardial Lead: Letter 1 Ann. Thorac. Surg., January 1, 2006; 81(1): 407 - 407. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dilaveris, A. Pantazis, G. Giannopoulos, A. Synetos, J. Gialafos, and C. Stefanadis Upgrade to biventricular pacing in patients with pacing-induced heart failure: can resynchronization do the trick? Europace, January 1, 2006; 8(5): 352 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Aranda Jr, G. W. Woo, R. S. Schofield, E. M. Handberg, J. A. Hill, A. B. Curtis, S. F. Sears, J. S. Goff, D. F. Pauly, and J. B. Conti Management of Heart Failure After Cardiac Resynchronization Therapy: Integrating Advanced Heart Failure Treatment With Optimal Device Function J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2193 - 2198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Perisinakis, N. Theocharopoulos, J. Damilakis, E. Manios, P. Vardas, and N. Gourtsoyiannis Fluoroscopically Guided Implantation of Modern Cardiac Resynchronization Devices: Radiation Burden to the Patient and Associated Risks J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2335 - 2339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kadish and M. Mehra Heart Failure Devices: Implantable Cardioverter-Defibrillators and Biventricular Pacing Therapy Circulation, June 21, 2005; 111(24): 3327 - 3335. [Full Text] [PDF]
|
|
|
|
|
|
H J Nesser, O-A Breithardt, and B K Khandheria Established and evolving indications for cardiac resynchronisation Heart, December 1, 2004; 90(suppl_6): vi5 - vi9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. McAlister, J. A. Ezekowitz, N. Wiebe, B. Rowe, C. Spooner, E. Crumley, L. Hartling, T. Klassen, and W. Abraham Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure Ann Intern Med, September 7, 2004; 141(5): 381 - 390. [Abstract] [Full Text] [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
